Solid state forms of racemic ilaprazole

Details Solid state forms of racemic ilaprazole Solid state forms of racemic ilaprazole

2011-08-16

2011-08-16

Morris, Patricia (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

active

07999110

ABSTRACT:
The invention relates to crystalline forms of racemic ilaprazole, 2[[(4-methoxy-3-methyl-2 -pyridinyl)-methyl]sulfinyl]-5-(1 H-pyrrol-1-yl) 1H-Benzimidazole. The invention also relates to a pharmaceutical composition for inhibiting gastric acid secretion comprising a crystalline Form of ilaprazole according to the invention in an amount effective to inhibit gastric acid secretion and a pharmaceutically acceptable carrier. The invention also provides methods of treatment for various acid-related gastrointestinal (GI) disorders.

REFERENCES:
patent: 6627646 (2003-09-01), Bakale et al.
patent: 95/23140 (1995-08-01), None
patent: WO 95/23140 (1995-08-01), None
patent: WO 2006/099810 (2006-09-01), None
patent: WO 2006/118534 (2006-11-01), None
Kim et al. II, “IY-81149, etc.,” Drugs of the Future 1999, 24(6), 618-621.
Kil et al., “Comparison of, etc.,” Journal of Autonomic Pharmacology, 2000, 20, 291-296.
Chemical & Engineering News, Feb. 2003, 32-35.
Brittain ed., “Polymorphism, etc.,” NY:Marcel Dekker, Inc., 1999, 1-2, 183-226, 235-238.
U.S. Pharmacopia #23, National Formulary #18, 1995, 1843-1844.
Muzaffar et al., “Polymorphism and Drug Availability, etc.,” J of Pharm. (Lahore), 1979, 1(1), 59-66.
Jain et al., “Polymorphism in Pharmacy”, Indian Drugs, 1986, 23(6) 315-329.
Taday et al., “Using Terahertz, etc.,” J of Pharm. Sci., 92(4), 2003, 831-838.
Concise Encyclopedia Chemistry, NY: Walter de Gruyter, 1993, 872-873.
Rowland & Tozer, “Clinical Pharmacokinetics, etc.,” 1995, p. 123.
Silverman, The Organic Chemistry of Drug Design and Drug Action, NY: Academic Press, 1993, 72-76.
Ulicky. Comprehensive Dictionary of Physical Chemistry, NY: Prentice Hall, 1992, p. 21.
Doelker, english translation of Ann. Pharm. Fr., 2002, 60: 161-176, pp. 1-39.
Doelker, english translation of S.T.P, Pratiques (1999), 9(5), 399-409, pp. 1033.
Otuska et al., “Effect of Polymorphic, etc.,” Chem. Pharm. Bull., 47(6) 852-856 (1999).
CMU Pharmaceutical polymorphism, internet, p. 1-3 (2002) (print out Apr. 3, 2008).
Singhal et al., “Drug Polymorphism, etc.,” Advanced Drug Delivery reviews 56, p. 335-347 (2004).
International Search Report for PCT/US2007/089127 dated May 15, 2008.
Kim et al., “IY-81149: Antiulcerative H+/K+-ATPase Inhibitor,” Drugs of the Future, 24(6), 618-621, 1999.

Affiliated with

Also associated with

Rating

Solid state forms of racemic ilaprazole does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Solid state forms of racemic ilaprazole, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solid state forms of racemic ilaprazole will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2640467